Oct 2026· Pediatric Quality & Safety· Vol 11, pp. e946· 0 citations· 22 references
Medicine
TL;DR
This initiative increased insulin pump use among both reference and minoritized groups of youth with T1D at a single institution and improved the efficiency of the insulin pump initiation process without a measurable increase in workload or diabetes-associated ketoacidosis events.
Abstract
Introduction: Automated insulin delivery is recommended for youth with type 1 diabetes (T1D). We aimed to increase the percentage of youth with T1D (diagnosed > 1 y) in 1 pediatric health system actively using an insulin pump from 56% to 65% within 18 months while reducing disparities based on race/ethnicity and insurance type. Methods: Following the Model for Improvement, local stakeholders organized this quality improvement project, identified a theory of change, and tested change ideas using the plan-do-study-act framework. We evaluated the primary outcome with a statistical process control chart, secondary outcomes with run charts, and other measures with descriptive statistics. Results: Between February 2024 and August 2025, insulin pump use increased from 56% to 65%, but disparities by race/ethnicity and insurance type persisted. Time from insulin pump education to initiation decreased by 19.8 days for patients who attended a group technology class. Non-face-to-face encounter volume decreased from 938 to 862 encounters per month, and diabetes-associated ketoacidosis events remained stable at 2% per month. Conclusions: This initiative increased insulin pump use among both reference and minoritized groups of youth with T1D at a single institution and improved the efficiency of the insulin pump initiation process without a measurable increase in workload or diabetes-associated ketoacidosis events. Although increased pump adoption among both groups is encouraging, continued advocacy at the individual and policy levels is needed to achieve optimal pump use and reduce disparities.
Abstract Objectives Our primary aim was to describe continuous glucose monitor (CGM) and insulin pump use in youth with T1D with a preferred language of care other than English (LOE) and examine associations between diabetes technology use and hemoglobin A1c (HbA1c) in this population. Methods We assessed baseline tech...
Samantha Goldklang, Kristen Carlin, Meenal Gupta et al.· Journal of Pediatric Endocri...· 0 citations
Technology utilization was associated with structural characteristics and youth-reported experiences, with youth discrimination identifying experiential factors that may influence adoption of diabetes technologies.
A. Addala, D. Garfias Silva, Lauren E. Figg et al.· Diabetes Technology & Therap...· 0 citations
Abstract Aim To assess the effectiveness of insulin pump therapy in improving glycemic control and to determine the frequency of insulin pump use among our type 1 diabetes (T1DM) patients and the factors associated with its use. Methods We conducted a retrospective chart review of 487 patients aged 2–18 years with a di...
S. Mahmoud, A. Shah, M. Yafi· European Journal of Public H...· 0 citations
Young children with T1D and their families face challenges related to diabetes management, some of which can be alleviated with use of diabetes technology, underscoring the importance of timely access in this population.
We investigated the impact of timing of insulin pump initiation on diabetes outcomes i...
R. Longendyke, J. Grundman, L. Holly et al.· Hormone Research in Paediatr...· 0 citations
Remote patient monitoring (RPM) of youth with type 1 diabetes (T1D) increases touchpoints for insulin dose adjustments and diabetes education. Stanford Children’s offered two continuous glucose monitor-based RPM programs to support youth with T1D. The 4T Program supported youth during the first year of T1D diagno...
M. Lee, V. Ritter, B. Shaw et al.· Hormone Research in Paediatr...· 0 citations
Type 1 Diabetes in children poses a large burden on health economics. 3233 new UK cases were diagnosed between April 2023 and March 2024,16% rise. NICE Technology Appraisal increased funding, with 55% using insulin pumps and 79% using real-time continuous glucose monitoring. Disparities persist, with higher HbA1c...
R. Patel, C. Bound, Z. Mengistu et al.· Hormone Research in Paediatr...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.